The PVT1 lncRNA is a novel epigenetic enhancer of MYC, and a promising risk-stratification biomarker in colorectal cancer

Overview of attention for article published in Molecular Cancer, November 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 61 Dimensions

Readers on

mendeley: 34 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 20,742 followers.

Highlighting work from #AjayGoel @cityofhope published in @BioMedCentral‘s Molecular Cancer: https://t.co/CHvpQaQ2h9 https://t.co/5cS4tVSfsp

25 Nov 2020

Reply Repost Favourite

The PVT1 lncRNA is a novel epigenetic enhancer of MYC, and a promising risk-stratification biomarker in colorectal cancer.: Related Articles The PVT1 lncRNA is a novel epigenetic enhancer of MYC, and a promising risk-stratification biomarker in… https://t.

07 Nov 2020

Reply Repost Favourite

The PVT1 lncRNA is a novel epigenetic enhancer of MYC, and a promising risk-stratification biomarker in colorectal cancer. https://t.co/pOKh3UJZhV

06 Nov 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.